CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
Predictive analytics is transforming clinical trial operations, from enrollment forecasting to risk-based monitoring. Here’s what sponsors need to know.
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
ECOA RESOURCES
-
Delve into how IQVIA eCOA captures patient data in a way that always keeps patients top of mind.
-
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
ECONSENT RESOURCES
-
Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
-
As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.
-
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
EPRO RESOURCES
-
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
Maximize efficiency today with a cloud-based user-friendly platform that seamlessly adapts to the future of phase 1-3 trials. Watch to see how Zelta can help.
-
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.